Literature DB >> 33171096

Racial and Workplace Disparities in Seroprevalence of SARS-CoV-2, Baton Rouge, Louisiana, USA.

Amy K Feehan, Cruz Velasco, Daniel Fort, Jeffrey H Burton, Eboni G Price-Haywood, Peter T Katzmarzyk, Julia Garcia-Diaz, Leonardo Seoane.   

Abstract

By using paired molecular and antibody testing for severe acute respiratory syndrome coronavirus 2 infection, we determined point prevalence and seroprevalence in Louisiana, USA, during the second phase of reopening. Infections were highly variable by race and ethnicity, work environment, and ZIP code. Census-weighted seroprevalence was 3.6%, and point prevalence was 3.0%.

Entities:  

Keywords:  Baton Rouge; COVID-19; Louisiana; SARS virus; SARS-CoV-2; United States; convalescence; coronavirus disease; cross-sectional studies; healthcare disparities; prevalence; respiratory infections; seroepidemiologic studies; severe acute respiratory syndrome coronavirus 2; viruses; zoonoses

Mesh：

Year:  2020        PMID： 33171096      PMCID： PMC7774581          DOI： 10.3201/eid2701.203808

Source DB:  PubMed          Journal:  Emerg Infect Dis        ISSN： 1080-6040            Impact factor:   6.883


  4 in total

1.  Seroprevalence of Antibodies to SARS-CoV-2 in 10 Sites in the United States, March 23-May 12, 2020.

Authors:  Fiona P Havers; Carrie Reed; Travis Lim; Joel M Montgomery; John D Klena; Aron J Hall; Alicia M Fry; Deborah L Cannon; Cheng-Feng Chiang; Aridth Gibbons; Inna Krapiunaya; Maria Morales-Betoulle; Katherine Roguski; Mohammad Ata Ur Rasheed; Brandi Freeman; Sandra Lester; Lisa Mills; Darin S Carroll; S Michele Owen; Jeffrey A Johnson; Vera Semenova; Carina Blackmore; Debra Blog; Shua J Chai; Angela Dunn; Julie Hand; Seema Jain; Scott Lindquist; Ruth Lynfield; Scott Pritchard; Theresa Sokol; Lynn Sosa; George Turabelidze; Sharon M Watkins; John Wiesman; Randall W Williams; Stephanie Yendell; Jarad Schiffer; Natalie J Thornburg
Journal:  JAMA Intern Med       Date:  2020-07-21       Impact factor: 21.873

2.  Prevalence of SARS-CoV-2 in Spain (ENE-COVID): a nationwide, population-based seroepidemiological study.

Authors:  Marina Pollán; Beatriz Pérez-Gómez; Roberto Pastor-Barriuso; Jesús Oteo; Miguel A Hernán; Mayte Pérez-Olmeda; Jose L Sanmartín; Aurora Fernández-García; Israel Cruz; Nerea Fernández de Larrea; Marta Molina; Francisco Rodríguez-Cabrera; Mariano Martín; Paloma Merino-Amador; Jose León Paniagua; Juan F Muñoz-Montalvo; Faustino Blanco; Raquel Yotti
Journal:  Lancet       Date:  2020-07-06       Impact factor: 79.321

3.  Performance Characteristics of the Abbott Architect SARS-CoV-2 IgG Assay and Seroprevalence in Boise, Idaho.

Authors:  Andrew Bryan; Gregory Pepper; Mark H Wener; Susan L Fink; Chihiro Morishima; Anu Chaudhary; Keith R Jerome; Patrick C Mathias; Alexander L Greninger
Journal:  J Clin Microbiol       Date:  2020-07-23       Impact factor: 5.948

4.  Seroprevalence of SARS-CoV-2 and Infection Fatality Ratio, Orleans and Jefferson Parishes, Louisiana, USA, May 2020.

Authors:  Amy K Feehan; Daniel Fort; Julia Garcia-Diaz; Eboni G Price-Haywood; Cruz Velasco; Eric Sapp; Dawn Pevey; Leonardo Seoane
Journal:  Emerg Infect Dis       Date:  2020-07-30       Impact factor: 6.883
  4 in total
  13 in total

1.  Ethnoracial Disparities in SARS-CoV-2 Seroprevalence in a Large Cohort of Individuals in Central North Carolina from April to December 2020.

Authors:  Cesar A Lopez; Clark H Cunningham; Sierra Pugh; Katerina Brandt; Usaphea P Vanna; Matthew J Delacruz; Quique Guerra; D Ryan Bhowmik; Samuel J Goldstein; Yixuan J Hou; Margaret Gearhart; Christine Wiethorn; Candace Pope; Carolyn Amditis; Kathryn Pruitt; Cinthia Newberry-Dillon; John L Schmitz; Lakshmanane Premkumar; Adaora A Adimora; Ralph S Baric; Michael Emch; Ross M Boyce; Allison E Aiello; Bailey K Fosdick; Daniel B Larremore; Aravinda M de Silva; Jonathan J Juliano; Alena J Markmann
Journal:  mSphere       Date:  2022-05-19       Impact factor: 5.029

2.  SARS-CoV-2 Viral Incidence, Antibody Point Prevalence, Associated Population Characteristics, and Vaccine Attitudes, South Carolina, February 2021.

Authors:  Melissa S Nolan; Virginie Daguise; Megan Davis; Joan M Duwve; Windsor Westbrook Sherrill; Moonseong Heo; Alain H Litwin; Mufaro Kanyangarara; Stella Self; Rongjie Huang; Jan M Eberth; Lídia Gual-Gonzalez; Mary K Lynn; Jeffrey Korte
Journal:  Public Health Rep       Date:  2022-03-10       Impact factor: 3.117

3.  SARS-CoV-2 seroprevalence among health care workers in a New York City hospital: A cross-sectional analysis during the COVID-19 pandemic.

Authors:  Usha Venugopal; Nargis Jilani; Sami Rabah; Masood A Shariff; Muzamil Jawed; Astrid Mendez Batres; Muhamed Abubacker; Sharika Menon; Anjana Pillai; Nehad Shabarek; Moiz Kasubhai; Vihren Dimitrov; Vidya Menon
Journal:  Int J Infect Dis       Date:  2020-10-16       Impact factor: 3.623

4.  Assessing the age specificity of infection fatality rates for COVID-19: systematic review, meta-analysis, and public policy implications.

Authors:  Andrew T Levin; William P Hanage; Nana Owusu-Boaitey; Kensington B Cochran; Seamus P Walsh; Gideon Meyerowitz-Katz
Journal:  Eur J Epidemiol       Date:  2020-12-08       Impact factor: 8.082

5.  SARS-CoV-2 seroprevalence and social inequalities in different subgroups of healthcare workers in Rio de Janeiro, Brazil.

Authors:  Roberta Fernandes Correia; Ana Carolina Carioca da Costa; Daniella Campelo Batalha Cox Moore; Saint Clair Gomes Junior; Maria Paula Carneiro de Oliveira; Maria Célia Chaves Zuma; Rômulo Gonçalves Galvani; Wilson Savino; Adriana Cesar Bonomo; Zilton Farias Meira Vasconcelos; Elizabeth Artmann
Journal:  Lancet Reg Health Am       Date:  2021-12-31

6.  Community versus individual risk of SARS-CoV-2 infection in two municipalities of Louisiana, USA: An assessment of Area Deprivation Index (ADI) paired with seroprevalence data over time.

Authors:  Amy K Feehan; Kara D Denstel; Peter T Katzmarzyk; Cruz Velasco; Jeffrey H Burton; Eboni G Price-Haywood; Leonardo Seoane
Journal:  PLoS One       Date:  2021-11-30       Impact factor: 3.240

7.  Socioeconomic Disparities in Severe Acute Respiratory Syndrome Coronavirus 2 Serological Testing and Positivity in New York City.

Authors:  Wil Lieberman-Cribbin; Marta Galanti; Jeffrey Shaman
Journal:  Open Forum Infect Dis       Date:  2021-10-17       Impact factor: 3.835

8.  Saffron and Its Major Ingredients' Effect on Colon Cancer Cells with Mismatch Repair Deficiency and Microsatellite Instability.

Authors:  Amr Amin; Aaminah Farrukh; Chandraprabha Murali; Akbar Soleimani; Françoise Praz; Grazia Graziani; Hassan Brim; Hassan Ashktorab
Journal:  Molecules       Date:  2021-06-24       Impact factor: 4.411

9.  Disparities in SARS-CoV-2 seroprevalence among individuals presenting for care in central North Carolina over a six-month period.

Authors:  Cesar A Lopez; Clark H Cunningham; Sierra Pugh; Katerina Brandt; Usaphea P Vanna; Matthew J Delacruz; Quique Guerra; Samuel Jacob Goldstein; Yixuan Jacob Hou; Margaret Gearhart; Christine Wiethorn; Candace Pope; Carolyn Amditis; Kathryn Pruitt; Cinthia Newberry-Dillon; John Schmitz; Lakshmanane Premkumar; Adaora A Adimora; Michael Emch; Ross Boyce; Allison E Aiello; Bailey K Fosdick; Daniel B Larremore; Aravinda M de Silva; Jonathan J J Juliano; Alena J Markmann
Journal:  medRxiv       Date:  2021-03-30

10.  Population-based prevalence surveys during the Covid-19 pandemic: A systematic review.

Authors:  Vinícius Bonetti Franceschi; Andressa Schneiders Santos; Andressa Barreto Glaeser; Janini Cristina Paiz; Gabriel Dickin Caldana; Carem Luana Machado Lessa; Amanda de Menezes Mayer; Julia Gonçalves Küchle; Paulo Ricardo Gazzola Zen; Alvaro Vigo; Ana Trindade Winck; Liane Nanci Rotta; Claudia Elizabeth Thompson
Journal:  Rev Med Virol       Date:  2020-12-04       Impact factor: 11.043
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.